Indian multinational pharmaceutical company Lupin Limited (Lupin) on Wednesday (December 6, 2023) announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Varenicline Tablets. The nod was given to 0.5 mg and 1 mg, to market a generic equivalent of Chantix Tablets, 0.5 […]
Monday
29 April 2024
29 April 2024